ArticleFrontiers in oncology2024
A novel fusion framework of deep bottleneck residual convolutional neural network for breast cancer classification from mammogram images.
Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Explainable Breast Cancer Detection Using Hierarchical Multi-Scale and Edge-Aware Transformer Networks.Bioengineering (Basel, Switzerland) · 2026Article
- Hierarchical Swin Transformer Ensemble with Explainable AI for Robust and Decentralized Breast Cancer Diagnosis.Bioengineering (Basel, Switzerland) · 2025Article
- Dual-branch dynamic hierarchical U-Net with multi-layer space fusion attention for medical image segmentation.Scientific reports · 2025Article
- (KAUH-BCMD) dataset: advancing mammographic breast cancer classification with multi-fusion preprocessing and residual depth-wise network.Frontiers in big data · 2025Article
- Detection of Masses in Mammogram Images Based on the Enhanced RetinaNet Network With INbreast Dataset.Journal of multidisciplinary healthcare · 2025Article
- Tomato seedling stem and leaf segmentation method based on an improved ResNet architecture.Frontiers in plant science · 2025Article
- CerviFusionNet: A multi-modal, hybrid CNN-transformer-GRU model for enhanced cervical lesion multi-classification.iScience · 2024Article
- Deep learning-based image annotation for leukocyte segmentation and classification of blood cell morphology.BMC medical imaging · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With over 2.1 million new cases of breast cancer diagnosed annually, the incidence and mortality rate of this disease pose severe global health issues for women. Identifying the disease's influence is the only practical way to lessen it immediately. Numerous research works have developed automated methods using different medical imaging to identify BC. Still, the precision of each strategy differs based on the available resources, the issue's nature, and the dataset being used. We proposed a novel deep bottleneck convolutional neural network with a quantum optimization algorithm for breast cancer classification and diagnosis from mammogram images. Two novel deep architectures named three-residual blocks bottleneck and four-residual blocks bottle have been proposed with parallel and single paths. Bayesian Optimization (BO) has been employed to initialize hyperparameter values and train the architectures on the selected dataset. Deep features are extracted from the global average pool layer of both models. After that, a kernel-based canonical correlation analysis and entropy technique is proposed for the extracted deep features fusion. The fused feature set is further refined using an optimization technique named quantum generalized normal distribution optimization. The selected features are finally classified using several neural network classifiers, such as bi-layered and wide-neural networks. The experimental process was conducted on a publicly available mammogram imaging dataset named INbreast, and a maximum accuracy of 96.5% was obtained. Moreover, for the proposed method, the sensitivity rate is 96.45, the precision rate is 96.5, the F1 score value is 96.64, the MCC value is 92.97%, and the Kappa value is 92.97%, respectively. The proposed architectures are further utilized for the diagnosis process of infected regions. In addition, a detailed comparison has been conducted with a few recent techniques showing the proposed framework's higher accuracy and precision rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.